Vincerx Pharma VINC Stock
Vincerx Pharma Price Chart
Vincerx Pharma VINC Financial and Trading Overview
| Vincerx Pharma stock price | 0.28 USD |
| Previous Close | 1.59 USD |
| Open | 1.55 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 1.51 - 1.66 USD |
| 52 Week Range | 0.63 - 1.95 USD |
| Volume | 51.91K USD |
| Avg. Volume | 72.9K USD |
| Market Cap | 32.51M USD |
| Beta (5Y Monthly) | 0.455281 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -15.85 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.67 USD |
VINC Valuation Measures
| Enterprise Value | -2709111 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2047244 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.9432799 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.042 |
Trading Information
Vincerx Pharma Stock Price History
| Beta (5Y Monthly) | 0.455281 |
| 52-Week Change | 14.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.95 USD |
| 52 Week Low | 0.63 USD |
| 50-Day Moving Average | 1.47 USD |
| 200-Day Moving Average | 1.17 USD |
VINC Share Statistics
| Avg. Volume (3 month) | 72.9K USD |
| Avg. Daily Volume (10-Days) | 71.79K USD |
| Shares Outstanding | 21.25M |
| Float | 15.61M |
| Short Ratio | 6.32 |
| % Held by Insiders | 25.96% |
| % Held by Institutions | 60.56% |
| Shares Short | 599.21K |
| Short % of Float | 3.89% |
| Short % of Shares Outstanding | 2.81% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -53.34% |
| Return on Equity (ttm) | -102.37% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -64524000 USD |
| Net Income Avi to Common (ttm) | -63284000 USD |
| Diluted EPS (ttm) | -2.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 39.77M USD |
| Total Cash Per Share (mrq) | 1.87 USD |
| Total Debt (mrq) | 3.28M USD |
| Total Debt/Equity (mrq) | 9.51 USD |
| Current Ratio (mrq) | 4.108 |
| Book Value Per Share (mrq) | 1.622 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -57668000 USD |
| Levered Free Cash Flow (ttm) | -34921624 USD |
Profile of Vincerx Pharma
| Country | United States |
| State | CA |
| City | Palo Alto |
| Address | 260 Sheridan Avenue |
| ZIP | 94306 |
| Phone | 650 800 6676 |
| Website | https://vincerx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 41 |
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.
Q&A For Vincerx Pharma Stock
What is a current VINC stock price?
Vincerx Pharma VINC stock price today per share is 0.28 USD.
How to purchase Vincerx Pharma stock?
You can buy VINC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vincerx Pharma?
The stock symbol or ticker of Vincerx Pharma is VINC.
Which industry does the Vincerx Pharma company belong to?
The Vincerx Pharma industry is Biotechnology.
How many shares does Vincerx Pharma have in circulation?
The max supply of Vincerx Pharma shares is 6.15M.
What is Vincerx Pharma Price to Earnings Ratio (PE Ratio)?
Vincerx Pharma PE Ratio is now.
What was Vincerx Pharma earnings per share over the trailing 12 months (TTM)?
Vincerx Pharma EPS is -15.85 USD over the trailing 12 months.
Which sector does the Vincerx Pharma company belong to?
The Vincerx Pharma sector is Healthcare.
Vincerx Pharma VINC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}